Interstitial Lung Disease Due to Systemic Disease Clinical Trials in Boston, Massachusetts
2 recruitingBoston, Massachusetts
Showing 1–2 of 2 trials
Recruiting
Phase 1
Nucleoside Therapy in Patients With Telomere Biology Disorders
Dyskeratosis CongenitaTelomere Biology DisordersHoyeraal-Hreidarsson Syndrome+4 more
Suneet Agarwal36 enrolled1 locationNCT06817590
Recruiting
Phase 2
Platform Clinical Study for Conquering Scleroderma
SclerodermaInterstitial Lung Disease Due to Systemic Disease
Scleroderma Research Foundation, Inc.400 enrolled34 locationsNCT06195072